Peptide Education Manager
Edit PT-141 / Bremelanotide
Name
Scientific / Common Name
Alternative Names
Slug (url-safe, unique)
Short Description (shown on cards)
A melanocortin receptor agonist with an FDA-approved use in a specific population, and separate areas of broader research interest.
Overview — What Is It? (paragraphs)
PT-141, also known by its molecular name bremelanotide, is a peptide that acts on melanocortin receptors in the central nervous system. It is distinct from many other sexual-wellness approaches because it works through brain signaling pathways rather than through blood-flow mechanisms. Bremelanotide, under the brand name Vyleesi, is FDA-approved specifically for acquired, generalized hypoactive sexual desire disorder (HSDD) in premenopausal women — a defined medical condition in a defined population. Use of bremelanotide outside of that specific approved indication and population, including as offered under the PT-141 name for other purposes, is considered investigational or off-label and is not FDA-approved for that use. Understanding this distinction — the molecule's one approved, well-studied use versus other areas where it may be discussed — is important context for anyone researching this compound.
Why Being Studied (one item per line)
Central nervous system melanocortin receptor signaling Sexual desire and arousal pathways (within the approved indication) Non-vascular mechanisms of sexual response Broader melanocortin pathway research outside the approved indication
How It May Work
Bremelanotide activates melanocortin receptors (primarily MC4R) in the central nervous system, a pathway distinct from the vascular mechanisms used by many other sexual-wellness therapies. This receptor activation has been studied for its relationship to sexual desire signaling in the brain.
Mechanism Pathway Steps (one per line)
Bremelanotide Central melanocortin receptor (MC4R) activation CNS sexual desire signaling pathways Clinical outcomes studied within its approved indication
Evidence Rating
Established / Approved Use
Strong Human Evidence
Moderate Human Evidence
Early Human Evidence
Preclinical Evidence
Emerging / Limited Evidence
Human Evidence
Randomized controlled clinical trials supported FDA approval of bremelanotide (Vyleesi) specifically for acquired, generalized hypoactive sexual desire disorder in premenopausal women. Evidence for other uses or populations is more limited and considered investigational.
Preclinical Evidence
Preclinical pharmacology research characterized melanocortin receptor binding and central nervous system activity prior to and alongside human trials.
What We Don't Know Yet
Evidence outside the specific FDA-approved indication and population (for example, use in men or for other purposes) is considerably more limited, and effectiveness and safety in those contexts has not been established through the same rigorous trial process.
Research Area Cards (format: Title: description — one per line)
Sexual Wellness: The approved indication for bremelanotide centers on hypoactive sexual desire disorder in a defined population.
Why Might Someone Discuss This With Their Provider?
Someone evaluating options for sexual desire concerns, or interested in melanocortin receptor pharmacology more broadly, may want to understand both the approved and investigational contexts for this compound.
Regulatory Status
Bremelanotide (brand name Vyleesi) is FDA-approved specifically for acquired, generalized hypoactive sexual desire disorder in premenopausal women. Use outside that approved indication and population, including PT-141 formulations offered for other purposes, is not FDA-approved for that use.
Important Considerations
This compound's one clearly approved use is narrow and population-specific. Any use outside that context should be discussed as an individualized, off-label decision with a licensed healthcare provider, who can review appropriateness, risks, and alternatives.
Related Peptide Slugs (one per line)
Is Combination Product?
Categories / Goals
Recovery & Repair
Metabolic Health
Weight Management
Performance
Muscle & Body Composition
Sleep & Recovery
Cognitive Health
Stress & Mood
Longevity & Healthy Aging
Cellular Energy
Skin, Hair & Aesthetics
Sexual Wellness
Search Tags (comma separated)
Last Reviewed Date
Display Order
Published
Featured
Save Peptide